2012-30738. Agency Information Collection Activities; Proposed Collection; Comment Request; Medicated Feed Mill License Application; Extension
-
Start Preamble
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice.
SUMMARY:
The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension and to allow 60 days for public comment in response to the notice. This notice solicits comments on the medicated feed mill licensing system.
DATES:
Submit written or electronic comments on the collection of information by February 19, 2013.
ADDRESSES:
Submit electronic comments on the collection of information to: http://www.regulations.gov. Submit written comments on the collection of information to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. All comments should be identified with the docket number found in brackets in the heading of this document.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Jonna Capezzuto, Office of Information Management, Food and Drug Administration, 1350 Piccard Dr., PIFO-410B, Rockville, MD 20850, 301-796-3794.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
Under the PRA (44 U.S.C. 3501-3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. “Collection of information” is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, Start Printed Page 75636including each proposed extension of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, FDA is publishing notice of the proposed collection of information set forth in this document.
With respect to the following collection of information, FDA invites comments on these topics: (1) Whether the proposed collection of information is necessary for the proper performance of FDA's functions, including whether the information will have practical utility; (2) the accuracy of FDA's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques, when appropriate, and other forms of information technology.
Medicated Feed Mill Licensing Application—21 CFR Part 515 (OMB Control Number 0910-0337)—Extension
The Animal Drug Availability Act (ADAA) of October 9, 1996, amended section 512 of the Federal Food, Drug, and Cosmetic Act to replace the system for the approval of specific medicated feed with a general licensing system for feed mills. Before passage of the ADAA, medicated feed manufacturers were required to obtain approval of Medicated Feed Applications (MFAs) in order to manufacture certain types of medicated feeds. An individual approved MFA was required for each and every applicable medicated feed. The ADAA streamlined the paperwork process for gaining approval to manufacture medicated feeds by replacing the MFA system with a facility license for each medicated feed manufacturing facility. Implementing regulations are at 21 CFR part 515.
FDA estimates the burden of this collection of information as follows:
Table 1—Estimated Annual Reporting Burden 1
21 CFR section and activity Number of respondents Number of responses per respondent Total annual responses Average burden per response Total hours Medicated Feed Mill License Application Using Form FDA 3448 (§ 515.10(b)) 20 1 20 .25 5 Supplemental Feed Mill License Application Using Form FDA 3448 (§ 515.11(b)) 40 1 40 .25 10 Voluntary Revocation of Medicated Feed Mill License (§ 515.23) 40 1 40 .25 10 Filing a Request for a Hearing on Medicated Feed Mill License (§ 515.30(c)) 1 1 1 4 4 Total 29 1 There are no capital costs or maintenance costs associated with this information collection. Table 2—Estimated Annual Recordkeeping Burden 1
21 CFR section Number of recordkeepers Number of responses per recordkeeper Total annual records Average burden per recordkeeper Total hours Maintenance of Records for Approved Labeling for Each “Type B” and “Type C” Labeling (§ 510.305) 950 1 950 0.03 28.5 1 There are no capital costs or maintenance costs associated with this information collection. Estimated annual reporting burden on industry is 29 hours as shown in table 1. Industry estimates it takes about 15 minutes (.25) to submit the application. We estimate 100 original and supplemental applications, and voluntary revocations for a total of 25 hours (100 submissions × .25 (15 minutes)). An additional 4 hours is added for the rare notice of opportunity for a hearing to not approve or revoke an application. Finally, we estimate 28.5 hours for maintaining and retrieving labels as required by 21 CFR 510.305. We estimated .03 hours for each of approximately 950 licensees. Total burden for reporting and recordkeeping would be 57.5 hours.
Start SignatureDated: December 17, 2012.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2012-30738 Filed 12-20-12; 8:45 am]
BILLING CODE 4160-01-P
Document Information
- Comments Received:
- 0 Comments
- Published:
- 12/21/2012
- Department:
- Food and Drug Administration
- Entry Type:
- Notice
- Action:
- Notice.
- Document Number:
- 2012-30738
- Dates:
- Submit written or electronic comments on the collection of information by February 19, 2013.
- Pages:
- 75635-75636 (2 pages)
- Docket Numbers:
- Docket No.FDA-2012-N-1181
- PDF File:
- 2012-30738.pdf